Amedisys (UnitedHealth / Optum)
Amedisys (UnitedHealth / Optum) — Home health & hospice — acquired by UnitedHealth’s Optum in 2025 · amedisys.com.
What it sells
Amedisys is a national home-health and hospice provider, acquired by UnitedHealth Group’s Optum in August 2025 (about $3.3 billion, after a DOJ antitrust suit — context, not VA money). As with LHC, veterans may receive Amedisys services through VA purchased community care generally; no direct national VA contract was documented in the sources reviewed.
The contract and the money
No direct national VA contract documented in this build’s research.
On the record
What the government’s own watchdogs and prosecutors have published about this company, newest first. The summaries are ours; the findings are theirs.
- Final judgment in DOJ’s Amedisys–UnitedHealth antitrust lawsuit (2025-12-12) — A federal judge approved the settlement allowing Optum’s acquisition to close: divestiture of at least 164 home-health and hospice locations across 19 states (about $528 million in annual revenue) and a $1.1 million Amedisys civil penalty for falsely certifying its antitrust filing.
- Amedisys Home Health Companies Agree to Pay $150 Million to Resolve False Claims Act Allegations (DOJ / HHS-OIG) (2014-04-23) — Amedisys paid $150 million over allegations it billed Medicare (2008–2010) for medically unnecessary nursing and therapy, or for patients who were not homebound — driven, the government alleged, by management pressure to provide care based on financial benefit rather than patient need.
If this company is in your chain
- Tell Your Story — this site publishes documented family records. If this company is in your veteran’s chain, your documents belong on the record next to ours.
- VA OIG Hotline: 800-488-8244 — report suspected wrongdoing, inadequate patient care, or mismanagement straight to the Inspector General.
Middlemen data checked 2026-10-25 against the sources cited on this page. If a figure or a fact here is wrong, tell us — corrections are the point of this site.